Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit antibody and antigen (recombinant protein)
Diagnostic anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit antibodies pairs and antigen for animal health (animal Avian/Bird/Poultry infectious disease ) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-VT-P211-Tg001-Ag01 | Recombinant Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit protein | 3090 |
GMP-VT-P211-Tg001-Ab01 | Anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit mouse monoclonal antibody (mAb) | 1953 |
GMP-VT-P211-Tg001-Ab02 | Anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit mouse monoclonal antibody (mAb) | 1953 |
GMP-VT-P211-Tg001-Ab03 | Anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit human monoclonal antibody (mAb) | 1953 |
GMP-VT-P211-Tg001-Ab04 | Anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-VT-P211-Tg001-Ag01 |
Product Name | Recombinant Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit protein |
Pathogen | Theileria equi |
Target/Biomarker | spike glycoprotein, S2 subunit |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Theileria equi spike glycoprotein, S2 subunit antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Theileria equi level test of animal Avian/Bird/Poultry with Infectious Bronchitis Virus - Variant 02 infection. |
Tag | His |
Products description | Recombinant Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-VT-P211-Tg001-Ab01, GMP-VT-P211-Tg001-Ab02 |
Product Name | Anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit mouse monoclonal antibody (mAb) |
Pathogen | Theileria equi |
Target/Biomarker | spike glycoprotein, S2 subunit |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Theileria equi spike glycoprotein, S2 subunit antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Theileria equi antibodies in Theileria equi level test of animal Avian/Bird/Poultry with Infectious Bronchitis Virus - Variant 02 infection. |
Tag | mFc |
Products description | Anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-VT-P211-Tg001-Ab03, GMP-VT-P211-Tg001-Ab04 |
Product Name | Anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit human monoclonal antibody (mAb) |
Pathogen | Theileria equi |
Target/Biomarker | spike glycoprotein, S2 subunit |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Theileria equi spike glycoprotein, S2 subunit antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Theileria equi antibodies in Theileria equi level test of animal Avian/Bird/Poultry with Infectious Bronchitis Virus - Variant 02 infection. |
Tag | hFc |
Products description | Anti-Infectious Bronchitis Virus - Variant 02 spike glycoprotein, S2 subunit human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Infectious bronchitis (IB) is one of the most prevalent avian diseases in the world’s poultry industry. IBV causes an acute highly contagious viral respiratory disease of chickens which is characterized by respiratory rales, coughing and sneezing. IBV is able to spread very rapidly in non-protected birds. It is shed via both the respiratory tract and the faeces, and can persist in the birds and the intestinal tract for several weeks or months.Effective control of IBV is particularly difficult due to genotype-phenotype diversity and continuing evolution of the causal coronavirus.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.